These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2506549)

  • 21. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
    Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
    Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic studies with triflubazam (ORF 8063): a new psychotherapeutic agent.
    Heilman RD; Bauer EW; Da Vanzo JP
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1022-32. PubMed ID: 4154182
    [No Abstract]   [Full Text] [Related]  

  • 23. [Problems in transferring data from animals to man in behavioral teratology].
    Pavlík A; Jelínek R; Benesová O
    Cas Lek Cesk; 1982 Sep; 121(37):1157-60. PubMed ID: 7139673
    [No Abstract]   [Full Text] [Related]  

  • 24. [Analogues of 3,4,5-trimethoxybenzamide. II. Synthesis and action on the central nervous system of nine alcoxybenzamides].
    Pifferi G; Monguzzi R; Banfi S; Carpi C
    Farmaco Sci; 1973 Oct; 28(10):818-29. PubMed ID: 4795784
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of aziprine on the central nervous system].
    Ponomareva AG
    Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
    [No Abstract]   [Full Text] [Related]  

  • 26. The central nervous system pharmacology of an anti-emetic dihydroindolone derivative.
    Holmes SW; Gylys JA
    Arzneimittelforschung; 1973 Sep; 23(9):1314-8. PubMed ID: 4204318
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of enprostil on food stimulated gastrin secretion in the rhesus monkey.
    Fisher PE; Wong A; Garay GL; Rosenkranz RP
    Proc West Pharmacol Soc; 1988; 31():37-40. PubMed ID: 3145504
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuropharmacological effects of ivermectin in mice.
    Kanwar RS; Varshneya C
    Indian J Physiol Pharmacol; 1995 Oct; 39(4):421-2. PubMed ID: 8582760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General pharmacology of nizatidine in animals.
    Bemis K; Bendele A; Clemens J; Deldar A; Gidda J; Hamelink J; Holland D; Lamishaw B; McGrath J; Shannon H
    Arzneimittelforschung; 1989 Feb; 39(2):240-50. PubMed ID: 2567169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BEHAVIORAL AND NEUROPHARMACOLOGICAL ACTIONS OF 3-METHYL-4-(1-PHENYL-2-PROPYLAMINO)-2-PHENYLMORPHOLINE AND ASSOCIATED 4-AMINOMORPHOLINES.
    KNAPP DL
    J Med Chem; 1964 Jul; 7():433-9. PubMed ID: 14221120
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological properties of a new fluoroquinolone on the central nervous system in rodents.
    Guiol C; Ledoussal C; Surgé JM
    Arzneimittelforschung; 1993 Jan; 43(1):56-60. PubMed ID: 8447850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological profile of 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go-10213), a new antiprotozoal agent, in comparison with metronidazole.
    David J; Grewal RS; Kaul CL; Nargunde HS; Wagle GP; Ringe SY; Acharya TK
    Arzneimittelforschung; 1985; 35(4):721-6. PubMed ID: 4015738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologically active substituted benzodiazepines and their effect on cardiovascular and central nervous system.
    Shukla S; Misra U; Bhalla M; Mukerjee D; Saxena AK; Sinha JN; Shanker K
    Boll Chim Farm; 2001; 140(1):53-8. PubMed ID: 11338779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective and therapeutic effects of gastrointestinal prostaglandins. Enprostil: a new modality. Proceedings of a symposium. November 13-14, 1985, Toronto, Canada.
    Am J Med; 1986 Aug; 81(2A):1-88. PubMed ID: 3092649
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental analysis of the cardiovascular and respiratory effects of PGE2 in gastric administration].
    Rosatti F; Lampa E; Spaziante G; Magliulo S; Giasi M; Imperatore A; Montanino C; Scognamiglio A; Marmo E
    Arch Ostet Ginecol; 1979; 84(3-4):185-202. PubMed ID: 554608
    [No Abstract]   [Full Text] [Related]  

  • 37. Prostaglandins and CCl4-induced liver cell mortality. The effect of the prostaglandin analogue enprostil.
    Bang S; Myren J; Naess O; Beraki K; Serck-Hanssen A; Arnesen K
    Scand J Gastroenterol; 1988 Oct; 23(8):931-4. PubMed ID: 3144036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central nervous system actions of some synthetic tetrahydrocannabinol derivatives.
    Domino EF; Hardman HF; Seevers MH
    Pharmacol Rev; 1971 Dec; 23(4):317-36. PubMed ID: 5003209
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on 20-isopropylidene PGE2 as a new aerosol bronchodilator.
    Murao M; Uchiyama K; Shida A; Sakai K; Yusa T; Yamaguchi T
    Adv Prostaglandin Thromboxane Res; 1980; 7():985-8. PubMed ID: 7369064
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of enprostil[(+/-)-11 alpha, 15 alpha-dihydroxy-9-keto-16-phenoxy-17,18,19,20-tetra-norprosta-4, 5,13-( +)- trienoic acid, methyl ester; EN] on 14C-aminopyrine (AP) accumulation in isolated canine parietal cells.
    Saito E; Natomi H; Sugano K; Seki A; Takaku F; Yasumura R; Matsuo Y
    Gastroenterol Jpn; 1989 Apr; 24(2):220. PubMed ID: 2501135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.